TruMed® Systems, Inc. Officially Recognized With SOC 2 Type 2 Compliance for Their Enterprise Security and Patient Data Protection Measures

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN DIEGO–(BUSINESS WIRE)–#AccuVax–TruMed® Systems, Inc. offers the emerging standard in vaccine storage and management with the AccuVax® Vaccine Management System. The AccuVax system safeguards vaccines, saves staff time for Top of License care, eliminates waste and loss for healthcare providers, and maximizes patient safety. TruMed has always been at the forefront of healthcare privacy and enterprise-grade security. TruMed has always had a full-suite of enterprise-grade security and carried cyber-insurance designed to meet and exceed HIPAA security provisions intended to protect sensitive patient, prescription data, and partner networks. Now TruMed and AccuVax has been recognized with SOC2® Type 2 Certification.

TruMed has achieved System and Organization Control 2 (SOC2) Type 2 compliance. Our recent SOC2 audit, performed by RSM US LLP, a leading accounting and advisory firm, documents the controls and process that support the criteria for Security, Availability, Processing Integrity, Confidentially, and Privacy Categories.

SOC2 is designed as a recognized standard for enterprise level security to document protection for systems, ePHI, HIPAA, and patient privacy protection. It requires companies to establish and follow strict information security policies and procedures encompassing the security, availability, processing, integrity, and confidentiality of customer data. The reports are intended to meet the needs of a broad range of users that need detailed information and independent assurance about the controls at an organization relevant to security, availability, confidentiality, processing integrity and privacy.

TruMed has always been committed to delivering the highest level of security programs, policies, and procedures. We know that it is critical for any healthcare provider to ensure their practice, their systems, and their patient care information remains safe and secure. Our customers carry this responsibility on their shoulders every single day, and it’s important that their partners approach that protection responsibility in the same way. That’s why today’s certification is such an important milestone for TruMed.

We welcome all customers and prospects who are interested in discussing our commitment to security and reviewing our SOC compliance reports to contact us at security@trumedsystems.com.

About TruMed Systems, Inc. and the AccuVax® Vaccine Management System

AccuVax is the fastest growing vaccine storage and handling solution in use at individual clinics, major health systems, and public healthcare facilities throughout the U.S. AccuVax is the only vaccine storage and management system that automates vaccine control and integrity, minimizes risks of incorrect vaccine delivery, and optimizes office workflow so that providers can focus on Top of License care. AccuVax is an integrated solution that includes hardware, software, online reports, software updates, training, optional EHR integrations, 24/7 support and maintenance, and industry-leading security. Learn more about AccuVax at www.AccuVax.com, 844-878-6331, or email info@AccuVax.com today.

Contacts

TruMed Systems, Inc.

Jesper Jensen, CEO

1-844-878-6331

jesper.jensen@trumedsystems.com
www.AccuVax.com

Staff

Recent Posts

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

52 minutes ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

58 minutes ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

1 hour ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

4 hours ago

Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort

Complete Pathologic Response in patient with cutaneous squamous cell carcinoma Partial Response in Stage 4…

6 hours ago

Healthcare Analytical Testing Services Market worth $12.48 billion by 2030 with 10.8% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 25, 2025 /PRNewswire/ -- The global Healthcare Analytical Testing Services Market,…

7 hours ago